DNA damage and differential cytotoxicity produced in human cells by 2-chloroethyl (methylsulfonyl)methanesulfonate (NSC 338947), a new DNA-chloroethylating agent
- PMID: 2983885
DNA damage and differential cytotoxicity produced in human cells by 2-chloroethyl (methylsulfonyl)methanesulfonate (NSC 338947), a new DNA-chloroethylating agent
Abstract
2-Chloroethyl (methylsulfonyl)methanesulfonate (CIEtSoSo) is of interest as a possible new chloroethylating agent because its simpler chemistry suggests that it will not generate the hydroxyethyl products which are produced by chloroethylnitrosoureas (CIEtNUs). The effects of CIEtSoSo on DNA were studied in IMR-90 and VA-13 human embryo cells by means of DNA alkaline elution analysis. IMR-90 are normal cells, whereas VA-13 cells are SV40 transformed and are deficient in DNA-guanine O6-alkyltransferase activity. The effects of CIEtSoSo were essentially the same as those of CIEtNUs in the following respects: DNA interstrand cross-links were produced in VA-13 cells but not in IMR-90 cells; the interstrand cross-links in VA-13 cells were formed after a delay of 6 to 12 h and appeared to undergo repair; DNA-protein cross-links were formed promptly in both cell types and appeared to be repaired; DNA strand breaks and alkali-labile lesions were produced and repaired, and differences were observed between the two cell types; and VA-13 cells were more sensitive than IMR-90 cells (dose modification factor, 5). The differential cytotoxicity against VA-13 cells was similar to that produced by noncarbamoylating CIEtNUs, and significantly larger than that produced by carbamoylating CIEtNUs. The results suggest that CIEtSoSo acts by chloroethylating guanine O6 positions in DNA.
Similar articles
-
Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate.Cancer Res. 1988 Jul 1;48(13):3603-6. Cancer Res. 1988. PMID: 2837318
-
DNA reactivity and in vitro cytotoxicity of the novel antitumor agent 1,5,2,4-dioxadithiepane-2,2,4,4-tetraoxide (NSC-348948) in human embryo cells.Cancer Res. 1986 Apr;46(4 Pt 1):1679-83. Cancer Res. 1986. PMID: 3509975
-
DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one.Cancer Res. 1984 May;44(5):1772-5. Cancer Res. 1984. PMID: 6713381
-
Mechanistic approaches to new nitrosourea development.Recent Results Cancer Res. 1981;76:141-52. doi: 10.1007/978-3-642-81565-2_13. Recent Results Cancer Res. 1981. PMID: 7015427 Review.
-
Identification of specific DNA lesions induced by three classes of chloroethylating agents: chloroethylnitrosoureas, chloroethylmethanesulfonates and chloroethylimidazotetrazines.Pharmacol Ther. 1985;31(1-2):153-63. doi: 10.1016/0163-7258(85)90042-7. Pharmacol Ther. 1985. PMID: 3031702 Review. No abstract available.
Cited by
-
Phase II trial of temozolomide in children with recurrent high-grade glioma.J Neurooncol. 2006 Mar;77(1):89-94. doi: 10.1007/s11060-005-9011-2. J Neurooncol. 2006. PMID: 16292488 Clinical Trial.
-
Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry.Cancer Chemother Pharmacol. 1989;25(3):149-55. doi: 10.1007/BF00689574. Cancer Chemother Pharmacol. 1989. PMID: 2557170
-
Pre-clinical evaluation of a novel chloroethylating agent, Clomesone.Br J Cancer. 1993 Mar;67(3):441-6. doi: 10.1038/bjc.1993.85. Br J Cancer. 1993. PMID: 8382507 Free PMC article.